Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

  Index>>Life Sciences>>Pharmaceutical

China Chemical Pharmaceutical Market Report, 2008

Published: Dec/2008

Hard Copy  USD $1,700
Pages:81 Electronic(PDF Unprintable  USD $1,800
Report Code: EB004 Enterprisewide( Printable and Editable)  USD $2,700
Hard Copy + Electronic PDF( Unprintable)  USD $1,800

By the end of Aug, 2008, the total output value of China’s chemical pharmaceutical industry was CNY 273.272 billion, among which, the total output value of active pharmaceutical ingredient (API) was CNY 122.467 billion and the total output value of chemical reagent was CNY 150.805 billion.

Total Output Value of China’s Chemical Pharmaceutical Industry, 2004-2008
Source: ResearchInChina

By the end of Sep, 2008, the total output of active pharmaceutical ingredient (API) in China was 1.675 million tons, of which, the output in Q12008 reached as many as 783,000 tons, up by 73.2% compared to Q1 2007.

API Output in China, 2005Q1-2008Q3
Source: ResearchInChina

This report gives an in-depth analysis of China’s chemical pharmaceutical industry, covering market segmentations, main products, and regional markets in China as well as the key players.

1. Overview of China Chemical Pharmaceutical Industry 
1.1 Development Course
1.2 Classification of Chemical Pharmaceutical Companies 
1.2.1 Reagent Manufacturers 
1.2.2 Active Pharmaceutical Ingredient (API) Manufacturers 

2. Overview of China Chemical Pharmaceutical Market 
2.1 Overview of The Market 
2.2 Characteristics of The Chemical Pharmaceutical Companies 

3.  China Active Pharmaceutical Ingredients (API) Market 
3.1 Overview of the Market
3.2 Market Performance 
3.2.1 Sales
3.2.2 Losses 
3.3 API Import & Export 
3.3.1 Export 
3.3.2 Import
3.4 Competition Patterns 
3.5 Market Performance of Major API Products
3.5.1 Cephalosporins
3.5.2 Vitamin C
3.5.3 Amoxycillin
3.5.4 Ceftriaxone Sodium
3.5.5 Clarithromycin

4. China Chemical Reagent Market 
4.1 Overview of the Market 
4.2 Market Performance 
4.2.1 Sales 
4.2.1 Losses
4.3 Import & Export
4.4 Market Performance of Major Reagent Products 
4.4.1 Lipitor
4.4.2 Clopidogrel
4.4.3 Rituximab
4.4.4 Fluticasone/Salmeterol
4.4.5 Epoetin Alfa
4.4.6 Single Nitroglycerin
4.4.7 Isosorbide dinitrate
4.4.8 Nitroglycerin

5. Regional Chemical Pharmaceutical Markets in China 
5.1 Overview
5.2 Shandong Province  
5.2.1 Overview 
5.2.2 Market Performance
5.2.3 Competition Patterns 
5.3 Jiangsu Province 
5.3.1 Overview 
5.3.2 Market Performance 
5.3.3 Competition Patterns
5.4 Zhejiang Province
5.4.1 Overview
5.4.2 Market Performance
5.4.3 Competition Patterns 
5.5 Hebei Province 
5.5.1 Overview 
5.5.2 Market Performance 
5.5.3 Competition Patterns 

6. Analysis of Key Companies 
6.1 Northeast Pharmaceutical Group Co., Ltd. 
6.1.1 Company Profile
6.1.2 Operations
6.2 Hubei Biocause Pharmaceutical Co., Ltd. 
6.2.1 Company Profile
6.2.2 Operations
6.3 Apeloa Co., Ltd. 
6.3.1 Company Profile
6.3.2 Operations
6.4 Shandong Xinhua Pharmaceutical Co., Ltd. 
6.4.1 Company Profile
6.4.2 Operations
6.5 Southwest Synthetic Pharmaceutical Co. Ltd.
6.5.1 Company Profile
6.5.2 Operations
6.6 Anhui Fengyuan Pharmaceutical Co., Ltd. 
6.6.1 Company Profile
6.6.2 Operations
6.7 LIVZON Pharmaceutical Group Inc.
6.7.1 Company Profile
6.7.2 Operations
6.8 Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
6.8.1 Company Profile
6.8.2 Operations
6.9 Beijing Double-Crane Pharmaceutical Co., Ltd. 
6.9.1 Company Profile
6.9.2 Operations
6.10 Hainan Haiyao Co., Ltd. 
6.10.1 Company Profile
6.10.2 Operations
Total Output Value of China Chemical Pharmaceutical Industry, 2004-2008 
Sales Revenue of China Chemical Pharmaceutical Industry, 2005-2008 
The Proportion of Large and Medium-sized Chemical Pharmaceutical Companies in China in 2007 
Assets of Chemical Pharmaceutical Companies in China by Size, Jan.-Nov.2007 
Losses of Chemical Pharmaceutical Companies in China by Size, Jan.-Nov.2007
API Output in China, 2005Q1-2008Q3
Output Value of API in China, 2005-2008 
Sales of API in China, 2005-2008 
Sales / Output Ratio of API in China, 2005-2008  
Accumulated Losses of API Manufacturers in China, 2006-2008 
China API Export Value, 2005-2008 
China API Import Value, 2005-2008 
Sales Revenue and Assets of China Top Ten API Manufacturers, Sep.2008 
Vitamin C Price in China, 2007-2008 
Total Output Value of Chemical Reagent in China, 2006-2008 
Sales of Chemical Reagent in China, 2006-2008
Sales / Output Ratio of Chemical Reagent in China, 2006-2008 
The Number of Chemical Reagent Manufacturers in Loss, 2006-2008 
Accumulated Losses of Chemical Reagent Manufacturers in China, 2006-2008 
China Monthly Antibiotic Reagent Import, 2007-2008 
Global Lipitor Sales, 2002-2008
Corresponding Proportion Taken by Nitrate Esters Medicines in 2007 
Top Ten Provinces by Chemical Pharmaceutical Assets in China in 2007 
Top Ten Provinces by Chemical Pharmaceutical Sales in China in 2007 
Top Ten Provinces by Chemical Pharmaceutical Output in China in 2007 
Regional Distribution of Chemical Pharmaceutical Companies in China, Jan.-Nov.2007 
Gross Profit Margin of Chemical Pharmaceutical in Shandong Province, 2004-2007 
Profits of API and Chemical Reagent in Shandong Province in 2007 
Top Five API Manufacturers in Shandong Province in 2007  
Top Five Chemical Reagent Manufacturers in Shandong Province in 2007 
Gross Profit Margin of Chemical Pharmaceutical in Jiangsu Province, 2004-2007 
Profits of API and Chemical Reagent in Jiangsu Province in 2007 
Top Five API Manufacturers in Jiangsu Province in 2007  
Top Five Chemical Reagent Manufacturers in Jiangsu Province in 2007 
Gross Profit Margin of Chemical Pharmaceutical in Zhejiang Province, 2004-2007 
Profits of API and Chemical Reagent in Zhejiang Province in 2007 
Top Five API Manufacturers in Zhejiang Province in 2007  
Top Five Chemical Reagent Manufacturers in Zhejiang Province in 2007 
The Number of Chemical Pharmaceutical Companies in Hebei Province in 2007 
Gross Profit Margin of Chemical Pharmaceutical in Hebei Province, 2004-2007 
Profits of API and Chemical Reagent in Hebei Province in 2007 
Top Five API Manufacturers in Hebei Province in 2007  
Top Five Chemical Reagent Manufacturers in Hebei Province in 2007 
Sales Revenue of Northeast Pharmaceutical Group Co., Ltd., 2001-2008 
API Revenue of Northeast Pharmaceutical Group Co., Ltd., 2005-2008
Chemical Reagent Revenue of Northeast Pharmaceutical Group Co., Ltd., 2005-2008
Regional Sales Revenue of Northeast Pharmaceutical Group Co., Ltd, Jun.2008
Sales Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-Jun.2008
Production Capacity of Hubei Biocause Pharmaceutical Co., Ltd.
Regional Sales Revenue of Hubei Biocause Pharmaceutical Co., Ltd in 2008
API Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-2008
Chemical Reagent Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-2008
Sales Revenue of Apeloa Co., Ltd., 2003-2008 
API Revenue of Apeloa Co., Ltd., 2003-2008

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1